Rosuvastatin and running training study
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at whether the cholesterol-lowering drug rosuvastatin affects how your body adapts to running training, and if it's safe to take while training. You would take rosuvastatin (or continue taking it) while keeping up your usual running routine, and we would monitor your fitness and safety over 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You need to take a statin medicine for high cholesterol, or your doctor has said you should start one.
- You run long distances at least 3 times a week and can keep that up for 3 months.
- You can do a special test on a bike or treadmill that measures your heart and lung fitness, and you can use a sports watch to track your runs.
- You have no allergies to statins or rosuvastatin, and you are not pregnant or breastfeeding.
- You have no serious health issues that would make exercise risky, like unstable heart problems, uncontrolled high blood pressure, or recent heart events.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral drug (HS-10510) in healthy people to check its safety and how the body handles it. It may help lower cholesterol, and some parts of the study look at how it works in people with higher cholesterol
This trial tests a low dose of rosuvastatin (a common statin) in people who have had trouble with statins before. The goal is to see if your body can tolerate this specific dose again, which could help lower your cholesterol without the past side effects.
This early study tests whether “liver fat” changes how a statin (rosuvastatin) works in children and teens. It may help doctors choose safer or more effective dosing in kids based on biology and a specific genetics marker.
This trial tests whether taking a statin (rosuvastatin) after a recent leg blood clot (DVT) and/or lung blood clot (PE) can lower the chance of future venous clots. You might benefit if you’re at risk for more clotting and can take the study medication safely.
This trial tests how certain statin drugs (medicines that lower cholesterol) affect heart and blood vessel function in healthy people. If you are healthy, you may help researchers understand how these drugs work.
This trial tests whether adding a new medicine, laroprovstat, to a standard cholesterol drug (rosuvastatin) is better at lowering bad cholesterol than the standard drug alone. It might help people who are at high risk for heart disease or stroke.
Hear when a new Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.